共 42 条
Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes
被引:98
作者:
Manfredi, Angelo A.
[1
]
Capobianco, Annalisa
[1
]
Esposito, Antonio
[2
]
De Cobelli, Francesco
[2
]
Canu, Tamara
[2
]
Monno, Antonella
[1
,4
]
Raucci, Angela
Sanvito, Francesca
[3
]
Doglioni, Claudio
[3
]
Nawroth, Peter P.
[5
]
Bierhaus, Angelika
[5
]
Bianchi, Marco E.
[4
]
Rovere-Querini, Patrizia
[1
]
Del Maschiot, Alessandro
[2
]
机构:
[1] H San Raffaele Sci Inst, Clin Immunol Unit, I-20132 Milan, Italy
[2] H San Raffaele Sci Inst, Dept Radiol, I-20132 Milan, Italy
[3] H San Raffaele Sci Inst, Dept Pathol, I-20132 Milan, Italy
[4] H San Raffaele Sci Inst, Chromatin Dynam Unit, I-20132 Milan, Italy
[5] Heidelberg Univ, Dept Med & Clin Chem 1, Heidelberg, Germany
关键词:
D O I:
10.4049/jimmunol.180.4.2270
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The mobilization of dendritic cells (DCs) from peripheral tissues is critical for the establishment of T cell-dependent immune responses or tolerance, because the physical interaction of DCs with naive T cells takes place in the T cell areas of lymph nodes. The autocrine/paracrine release of the high mobility group box 1 (HMGB1) nuclear protein by DCs controls the outcome of the DC-T cell interaction, influencing the priming/Th1 polarization of naive T cells. We herein present evidence that the receptor for advanced glycation end products (RAGE), a multiligand member of the Ig superfamily of cell-surface molecules that acts as a receptor for HMGB1, plays a nonredundant role in DC homing to lymph nodes. We used noninvasive imaging by magnetic resonance and immunohistochemistry to track DCs after s.c. injection in the footpad of wild-type(+/+) or RAGE(-/-) mice. Maturing DCs expressing RAGE effectively migrated in both conditions. In contrast, RAGE(-/-) DCs failed to reach the draining popliteal lymph nodes of +/+ and -/- mice, indicating that the integrity of RAGE is required for DC mobilization. Thus the HMGB1-RAGE pathway is a checkpoint in DC maturation and function and a candidate for targeted therapies.
引用
收藏
页码:2270 / 2275
页数:6
相关论文